Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after ...

Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...

A first-of-its-kind study testing an mRNA vaccine for norovirus, the highly contagious winter vomiting bug, is launching in ...

For the second time in recent months, a U.K. agency said the limited benefits of a new Alzheimer’s drug do not justify its ...

Wes Streeting has suggested that no-show patients may be fined in the future because NHS lost £1 billion to nearly eight million missed NHS appointments in the last year.

Donanemab, given as an infusion every four weeks, has shown to slow down cognitive decline by 4-7 months in clinical studies.

Initiatives aimed at getting homeless people healthier and off the streets are running up against new, aggressive crackdowns.

The government has been urged to prioritize funding and fast-track the implementation of the National Community Health ...

The platform reads the results of electrocardiogram tests, which record the electrical activity of the heart | ITV National ...

Public service trade union Fórsa has warned the health service recruitment embargo is impacting on the system and could lead ...

This is the second time a new Alzheimer's treatment has been rejected by the health spending watchdog in a matter of months.

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending ...